A massive corporate expansion in Bend for a key player in biotech could eventually open some promising new research and development avenues tied to Covid-19. The Lonza Group which provides healthcare solutions worldwide is planning a $10 million dollar expansion of its current facility in Bend and will include new suites dedicated to early phase testing of trial drug products to assess their safety and effectiveness. The company is already working with Moderna on a Covid-19 vaccine at its facility in New Hampshire. Lonza has more than 400 employees in Bend now – and the expansion will add another 35 to its campus on Empire Blvd. Construction starts this month and the expansion’s expected to be completed in two years.